Skip to main content
The Permian isn't standing still. Neither should your strategy. Join us for breakfast!
General Interest
Refining & Processing
Drilling & Production
Exploration & Development
Pipelines & Transportation
Sections
General Interest
Refining & Processing
Drilling & Production
Exploration & Development
Pipelines & Transportation
LNG
Energy Transition
Industry Statistics
Members Only
Special
Webcasts
White Papers
Podcast
Magazine
Surveys
Research
Events
Submit an Article
Iran war
Contact
About Us
Magazine Subscription
Newsletter Subscription
Advertise
Contact Us
Privacy Policy
Terms & Conditions
Affiliated Brands
OFFSHORE
ENERGYTECH
MICROGRID KNOWLEDGE
OGJ RESEARCH
Follow us on
http://www.facebook.com/ogjonline
https://www.linkedin.com/company/oil-&-gas-journal
http://twitter.com/ogjonline
Recent Quotes
View Full List
My Watchlist
Csl Ltd ADR
Currenc Group Inc. - Ordinary Shares
Merit Medical Systems, Inc. - Common Stock
Meta Platforms, Inc. - Class A Common Stock
MongoDB, Inc. - Class A Common Stock
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Edwards Lifesciences
(NY:
EW
)
89.91
+0.84 (+0.94%)
Delayed Quote
Updated: 11:30 AM EDT, Oct 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Edwards Lifesciences
< Previous
1
2
3
4
5
6
7
Next >
FDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease
October 21, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
October 07, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Host Investor Event in Conjunction With TCT
October 05, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
October 01, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences Comments on TAVR National Coverage Decision
September 10, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
September 02, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences Reports Second Quarter Results
July 23, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026
July 16, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves
June 26, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue
May 02, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference
April 28, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences Reports First Quarter Results
April 23, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
April 16, 2026
Issued on behalf of VentriPoint Diagnostics Ltd.
From
USA News Group
Via
GlobeNewswire
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
April 16, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
March 30, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose
February 26, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences
February 19, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
February 13, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights
February 12, 2026
Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
From
Halper Sadeh LLC
Via
GlobeNewswire
Edwards Lifesciences Reports Fourth Quarter Results
February 10, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
February 03, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference
February 02, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
AI Diagnostics: The End of the High-Cost Imaging Era
January 16, 2026
Issued on behalf of VentriPoint Diagnostics Ltd.
From
Equity Insider
Via
GlobeNewswire
Edwards Comments on JenaValve Acquisition
January 09, 2026
From
Edwards Lifesciences Corporation
Via
Business Wire
FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy
December 23, 2025
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
December 04, 2025
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease
November 09, 2025
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences Announces CFO Transition Plan
October 30, 2025
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences Reports Third Quarter Results
October 30, 2025
From
Edwards Lifesciences Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
